mobocertinib succinate | Interleukin Related interleukin-related.com

Product Name :
mobocertinib succinate

Search keywords :
Mobocertinib (succinate)

drugId :
null

Target Vo:
EGFR exon 20 insertion mutations

Target Vo Short Name :
EGFR exon 20 insertion mutations

Moa_Name:
EGFR exon 20 insertion mutations inhibitors

First Approval Country :
United States

First Approval Date Filter:
2021

Origin Company_Name :
Ariad Pharmaceuticals Inc

Active Company_Name :
Millennium Pharmaceuticals Inc

Active Indication_Name:
Carcinoma, Non-Small-Cell Lung

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Fibronectin Rabbit mAb Autophagy
PU.1 Rabbit mAb In Vitro
FNDC5 Antibody: FNDC5 Antibody is an unconjugated, approximately 12/20 kDa, rabbit-derived, anti-FNDC5 polyclonal antibody. FNDC5 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, ICC, IF expriments in human, mouse, and predicted: rat, chicken, dog, rabbit background without labeling.

Author: Interleukin Related

Related Posts